glycine has been researched along with pevonedistat in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Guy, RK; Hammill, JT; Kim, HS; Min, J; Rector, J; Schulman, BA; Scott, DC; Singh, B | 1 |
| Hosono, N | 1 |
| Cordes, BA; Iempridee, T; Kraus, RJ; Lambert, PF; Lee, DL; Mertz, JE; Patel, P; Sathiamoorthi, S; Yu, X; Yuan, X | 1 |
| Dutta, R; Jeng, MY; Mannis, GN; Tan, IT; Zhang, TY | 1 |
1 review(s) available for glycine and pevonedistat
| Article | Year |
|---|---|
[New therapeutic agents for acute myeloid leukemia].
Topics: Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cyclopentanes; Drug Approval; Flavonoids; Glycine; Humans; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Phenylurea Compounds; Piperidines; Pyridines; Pyrimidines; Sulfonamides; United States; United States Food and Drug Administration | 2019 |
1 trial(s) available for glycine and pevonedistat
| Article | Year |
|---|---|
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies.
Topics: Aged, 80 and over; Aniline Compounds; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclopentanes; Disease-Free Survival; Female; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Pyrazines; Pyridines; Pyrimidines; Retrospective Studies; Sulfonamides; Survival Rate | 2020 |
2 other study(ies) available for glycine and pevonedistat
| Article | Year |
|---|---|
Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.
Topics: Amides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cullin Proteins; Cyclopentanes; Drug Design; Fibroblasts; Glycine; Humans; Intracellular Signaling Peptides and Proteins; NEDD8 Protein; Protein Domains; Protein Interaction Mapping; Pyrazoles; Pyridones; Pyrimidines; Reactive Oxygen Species; Structure-Activity Relationship; Ubiquitin-Conjugating Enzymes | 2019 |
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
Topics: Cell Line, Tumor; Cyclopentanes; Deferoxamine; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Glycine; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Iron Chelating Agents; Isoquinolines; Lymphocytes; Morpholines; Piperazines; Prolyl-Hydroxylase Inhibitors; Promoter Regions, Genetic; Protein Binding; Pyrimidines; Pyrones; Response Elements; RNA, Small Interfering; Signal Transduction; Trans-Activators; Tumor Suppressor Protein p53; Virus Activation | 2020 |